Valneva SE (VALN) Enterprise Value (2019 - 2026)

Valneva SE (VALN) posted quarterly Enterprise Value of -$119.8 million for Q1 2026, up 31.19% year-on-year from -$91.3 million in Q1 2025, and up 4.0% on a QoQ basis from -$124.8 million in Q4 2025.

Valneva SE (VALN) Enterprise Value (2019 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Enterprise Value for 8 consecutive years, with -$119.8 million the latest figure, recorded in Q1 2026.

  • Quarterly Enterprise Value rose 31.19% year-over-year to -$119.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$119.8 million (up 31.19% YoY) and the FY2025 annual result came in at -$124.8 million, up 35.32% from the prior year.
  • Enterprise Value improved to -$119.8 million in Q1 2026 per VALN's latest filing, from -$124.8 million in the prior quarter.
  • Over the last five years, Enterprise Value for VALN reached as high as -$119.8 million in Q1 2026 and fell as low as -$382.6 million in Q2 2022.
  • A 5-year average of -$218.2 million and a median of -$192.9 million in 2024 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2022 — Enterprise Value sank 716230.0% — and 2023, when it surged 55.61%.
  • Year by year, Enterprise Value stood at -$326.1 million in 2022, then jumped by 55.61% to -$144.7 million in 2023, then tumbled by 33.29% to -$192.9 million in 2024, then jumped by 35.32% to -$124.8 million in 2025, then rose by 4.0% to -$119.8 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$119.8 million, -$124.8 million, and -$163.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -283.54 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - -32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -7.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -8.75 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -5.18 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -1.91 Bn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -119.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -119.79 Mn
Dec 31, 2025 -124.78 Mn
Sep 30, 2025 -163.25 Mn
Jun 30, 2025 -185.05 Mn
Mar 31, 2025 -174.10 Mn
Dec 31, 2024 -192.91 Mn
Sep 30, 2024 -177.90 Mn
Jun 30, 2024 -149.54 Mn
Mar 31, 2024 -201.01 Mn
Dec 31, 2023 -144.74 Mn
Sep 30, 2023 -194.88 Mn
Jun 30, 2023 -232.61 Mn
Mar 31, 2023 -289.59 Mn
Dec 31, 2022 -326.06 Mn
Sep 30, 2022 -297.05 Mn
Jun 30, 2022 -382.61 Mn
Mar 31, 2022 -354.20 Mn
Dec 31, 2021 -45,518.17
Sep 30, 2021 -282.15 Mn
Jun 30, 2021 -375.30 Mn